Crossmark

Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia

Crossref DOI link: https://doi.org/10.1016/j.htct.2024.02.028

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chiesa, Sitânia https://orcid.org/0000-0003-2593-8364
Rego, Eduardo Magalhães https://orcid.org/0000-0003-1567-4086
Teich, Vanessa

Madeira, Maria Isabel Ayrosa

de Figueiredo Pontes, Lorena Lobo

Traina, Fabiola

Marani, Leticia Olops https://orcid.org/0000-0003-1579-9700
Funding

Funding for this research was provided by:

American Society of Hematology

Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/08135-2)
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-04-09
More Information

This article is maintained by: Elsevier

Article Title: Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2024.02.028

Content Type: article

Copyright: © 2024 Published by Elsevier España, S.L.U. on behalf of Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.

Document is current

Any future updates will be listed below